HROW
HEALTHCAREHarrow Inc
$40.27-0.23 (-0.57%)PRE
Live · NASDAQ · May 9, Close
AI Insight
What's Moving HROW Today?
No stock-specific AI insight has been generated for HROW yet. Check back soon — insights are generated from recent news analysis.
52-Week Range
$21.12$54.85
$40.27
Fundamentals
Market Cap$1.5B
P/E Ratio—
EPS$-0.14
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume713K
Avg Volume (10D)—
Shares Outstanding37.3M
HROW News
20 articles- Relay Therapeutics, Inc. (RLAY) Reports Q1 Loss, Lags Revenue EstimatesYahoo Finance·May 5, 2026
- Analysts Estimate Harrow (HROW) to Report a Decline in Earnings: What to Look Out forYahoo Finance·May 4, 2026
- Is Harrow, Inc. (HROW) A Good Stock To Buy Now?Yahoo Finance·Apr 30, 2026
- Harrow To Report First Quarter 2026 Financial Results After Market Close on May 11, 2026Yahoo Finance·Apr 27, 2026
- Harrow Announces the Issuance of J-Code for IOPIDINE® 1%Yahoo Finance·Apr 16, 2026
- Top Growth Companies With Strong Insider Ownership April 2026Yahoo Finance·Apr 14, 2026
- LogiCare3PL Selected as Distribution Partner by HarrowYahoo Finance·Apr 14, 2026
- Assessing Harrow (HROW) Valuation After US$8.1 Million In Recent Insider Stock SalesYahoo Finance·Apr 14, 2026
- What Harrow (HROW)'s New US$50 Million Senior Notes Offering Means For ShareholdersYahoo Finance·Mar 28, 2026
- Harrow Announces Pricing of $50.0 Million Offering of Senior Unsecured Notes Due 2030GlobeNewswire Inc.·Mar 24, 2026
- A Major Investor Just Sold $7.8 Million in Harrow Stock -- Is This a Sell Signal?Motley Fool·Mar 24, 2026
- Harrow Announces Add-On Offering of $50.0 Million of Senior Unsecured Notes to Support GrowthYahoo Finance·Mar 24, 2026
- Harrow Announces Three Abstracts Accepted for Presentation at ASCRS 2026 Annual MeetingYahoo Finance·Mar 18, 2026
- Harrow Inc (HROW) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ExpansionsYahoo Finance·Mar 10, 2026
- A Look At Harrow (HROW) Valuation After Mixed Q4 Results And 2026 Profitability ConcernsYahoo Finance·Mar 6, 2026
- Investment Manager Fully Exits Immunome Stock in $37.3 Million Sale, According to Latest SEC FilingMotley Fool·Mar 4, 2026
- Investment Manager Sells $5.1 Million Worth of LQDA Stock, According to Recent SEC FilingMotley Fool·Mar 4, 2026
- Harrow to Present at Leerink Partner’s 2026 Global Healthcare ConferenceYahoo Finance·Mar 4, 2026
- Why Harrow, An IBD 50 Stock Up 32% Since January, Just CrashedYahoo Finance·Mar 3, 2026
- Harrow Q4 Earnings Call HighlightsMarketbeat·Mar 3, 2026
All 20 articles loaded
Price Data
Open$40.59
Previous Close$40.50
Day High$40.93
Day Low$39.30
52 Week High$54.85
52 Week Low$21.12
52-Week Range
$21.12$54.85
$40.27
Fundamentals
Market Cap$1.5B
P/E Ratio—
EPS$-0.14
Dividend Yield—
Dividend / Share—
ROE-0.1%
Profit Margin-0.0%
Debt / Equity—
Trading
Volume713K
Avg Volume (10D)—
Shares Outstanding37.3M
About Harrow Inc
Harrow Health, Inc. is an ophthalmology-focused healthcare company. The company is headquartered in San Diego, California.
HEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Company Details
Security TypeStock
ExchangeNASDAQ
CurrencyUSD
Round Lot—
SICDRUG MANUFACTURERS - SPECIALTY & GENERIC
CIK—
Composite FIGI—
Share Class FIGI—